Under the leadership of Dr Serhat Gumrukcu and with the collaboration of the in the field, Seraph Research Institute is aiming to be among the world’s leading institutions in fighting against HIV/AIDS through the pursuit of novel and innovative prevention, treatment, and cure strategies.
Individuals with HIV that take their medicine, antiretroviral therapy (ART), as prescribed and maintain an undetectable viral load can live long, healthy lives and have effectively no risk of sexually transmitting HIV to a partner. In the recent years ART has changed HIV-infection from a death sentence to a chronic disease. However, ART requires life-long therapy that is expensive and has the risk of significant side effects. In addition, drug resistance is growing, requiring new and often more costly products. From a person-centered approach, life-long therapy can be challenging and, unfortunately, stigma and discrimination remain strong throughout the world.